Prices of 41 medicines for diabetes, heart and liver-related diseases reduced
Prices of 41 medicines and six formulations commonly used to treat diseases like diabetes, heart, and liver have been reduced. This decision was taken in the 143rd meeting of NPPA to ensure that the prices of essential medicines remain affordable for the public. This decision was taken in the 143rd meeting of NPPA.

The government has reduced the prices of 41 medicines and six formulations commonly used to treat diseases like diabetes, heart, and liver. According to a notification issued by the Department of Pharmaceuticals and the National Pharmaceutical Pricing Authority (NPPA), antacids, multivitamins, and antibiotics are among the medicines that will become cheaper.
Pharma companies have been ordered to promptly notify dealers and stockists about reduced prices for a range of medications.
In order to guarantee that the public can continue to afford essential medications, the NPPA made this decision at its 143rd meeting. With more than 10 crore patients suffering from diabetes, India has one of the highest rates of diabetes incidence worldwide. nations that are anticipated to gain from price reductions.
With effect from April 1, the Department of Pharmaceuticals published last month its annual revised ceiling prices for 923 scheduled drug formulations and revised retail prices for 65 formulations.